annual D&A:
$6.69B+$1.75B(+35.55%)Summary
- As of today (May 29, 2025), AZN annual depreciation & amortization is $6.69 billion, with the most recent change of +$1.75 billion (+35.55%) on December 31, 2024.
- During the last 3 years, AZN annual D&A has risen by +$2.59 billion (+63.04%).
- AZN annual D&A is now at all-time high.
Performance
AZN Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.28B+$570.00M(+79.83%)Summary
- As of today (May 29, 2025), AZN quarterly depreciation & amortization is $1.28 billion, with the most recent change of +$570.00 million (+79.83%) on March 31, 2025.
- Over the past year, AZN quarterly D&A has increased by +$29.00 million (+2.31%).
- AZN quarterly D&A is now -53.95% below its all-time high of $2.79 billion, reached on September 30, 2021.
Performance
AZN quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$5.09B+$29.00M(+0.57%)Summary
- As of today (May 29, 2025), AZN TTM depreciation & amortization is $5.09 billion, with the most recent change of +$29.00 million (+0.57%) on March 31, 2025.
- Over the past year, AZN TTM D&A has increased by +$407.00 million (+8.68%).
- AZN TTM D&A is now -6.48% below its all-time high of $5.45 billion, reached on March 31, 2023.
Performance
AZN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AZN Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +35.5% | +2.3% | +8.7% |
3 y3 years | +63.0% | -1.9% | +10.4% |
5 y5 years | +77.8% | +52.7% | +29.7% |
AZN Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +63.0% | -29.3% | +79.8% | -6.5% | +35.3% |
5 y | 5-year | at high | +130.9% | -54.0% | +644.1% | -6.5% | +78.6% |
alltime | all time | at high | +2656.0% | -54.0% | +644.1% | -6.5% | +1854.2% |
AZN Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $1.28B(+79.8%) | $5.09B(+0.6%) |
Dec 2024 | $6.69B(+35.5%) | $714.00M(-60.7%) | $5.07B(-3.1%) |
Sep 2024 | - | $1.82B(+42.1%) | $5.22B(+11.4%) |
Jun 2024 | - | $1.28B(+1.9%) | $4.69B(+0.1%) |
Mar 2024 | - | $1.25B(+43.6%) | $4.69B(-5.0%) |
Dec 2023 | $4.93B(-6.1%) | $874.00M(-31.8%) | $4.93B(-7.2%) |
Sep 2023 | - | $1.28B(+0.5%) | $5.31B(-1.0%) |
Jun 2023 | - | $1.28B(-15.0%) | $5.37B(-1.5%) |
Mar 2023 | - | $1.50B(+19.8%) | $5.45B(+3.7%) |
Dec 2022 | $5.25B(+28.1%) | $1.25B(-6.0%) | $5.25B(+39.6%) |
Sep 2022 | - | $1.33B(-1.7%) | $3.76B(-27.9%) |
Jun 2022 | - | $1.36B(+3.7%) | $5.22B(+13.1%) |
Mar 2022 | - | $1.31B(-654.7%) | $4.61B(+12.5%) |
Dec 2021 | $4.10B(+41.6%) | -$236.00M(-108.5%) | $4.10B(-16.0%) |
Sep 2021 | - | $2.79B(+270.3%) | $4.88B(+68.6%) |
Jun 2021 | - | $753.00M(-5.5%) | $2.90B(+1.5%) |
Mar 2021 | - | $797.00M(+46.5%) | $2.85B(-1.5%) |
Dec 2020 | $2.90B(-23.0%) | $544.00M(-32.1%) | $2.90B(-27.5%) |
Sep 2020 | - | $801.00M(+12.8%) | $4.00B(+2.2%) |
Jun 2020 | - | $710.00M(-15.6%) | $3.91B(-0.4%) |
Mar 2020 | - | $841.00M(-48.8%) | $3.93B(+4.4%) |
Dec 2019 | $3.76B(+0.2%) | $1.64B(+129.5%) | $3.76B(-0.5%) |
Sep 2019 | - | $716.00M(-1.5%) | $3.78B(+0.5%) |
Jun 2019 | - | $727.00M(+7.5%) | $3.76B(+1.2%) |
Mar 2019 | - | $676.00M(-59.3%) | $3.72B(-0.9%) |
Dec 2018 | $3.75B(+23.6%) | $1.66B(+138.1%) | $3.75B(+17.4%) |
Sep 2018 | - | $698.00M(+2.0%) | $3.20B(+1.4%) |
Jun 2018 | - | $684.00M(-3.5%) | $3.15B(+2.2%) |
Mar 2018 | - | $709.00M(-36.0%) | $3.09B(+1.7%) |
Dec 2017 | $3.04B(+28.8%) | $1.11B(+69.0%) | $3.04B(+20.5%) |
Sep 2017 | - | $655.00M(+6.3%) | $2.52B(+1.8%) |
Jun 2017 | - | $616.00M(-6.4%) | $2.48B(+1.2%) |
Mar 2017 | - | $658.00M(+11.5%) | $2.45B(+3.8%) |
Dec 2016 | $2.36B(-17.4%) | $590.00M(-3.4%) | $2.36B(-5.1%) |
Sep 2016 | - | $611.00M(+4.1%) | $2.48B(+1.6%) |
Jun 2016 | - | $587.00M(+3.2%) | $2.44B(-5.0%) |
Mar 2016 | - | $569.00M(-20.5%) | $2.57B(-9.8%) |
Dec 2015 | $2.85B(-13.1%) | $716.00M(+25.4%) | $2.85B(-9.7%) |
Sep 2015 | - | $571.00M(-20.3%) | $3.16B(-8.1%) |
Jun 2015 | - | $716.00M(-15.7%) | $3.44B(+0.5%) |
Mar 2015 | - | $849.00M(-16.8%) | $3.42B(+4.2%) |
Dec 2014 | $3.28B(-28.4%) | $1.02B(+20.0%) | $3.28B(-32.6%) |
Sep 2014 | - | $851.00M(+21.9%) | $4.87B(+10.5%) |
Jun 2014 | - | $698.00M(-2.0%) | $4.40B(-5.2%) |
Mar 2014 | - | $712.00M(-72.7%) | $4.64B(+1.3%) |
Dec 2013 | $4.58B(+82.0%) | $2.60B(+571.4%) | $4.58B(+67.1%) |
Sep 2013 | - | $388.00M(-58.7%) | $2.74B(-11.5%) |
Jun 2013 | - | $939.00M(+44.2%) | $3.10B(+16.1%) |
Mar 2013 | - | $651.00M(-14.8%) | $2.67B(+6.0%) |
Dec 2012 | $2.52B(-1.3%) | $764.00M(+2.6%) | $2.52B(-7.6%) |
Sep 2012 | - | $745.00M(+46.1%) | $2.72B(+8.0%) |
Jun 2012 | - | $510.00M(+2.2%) | $2.52B(-0.0%) |
Mar 2012 | - | $499.00M(-48.6%) | $2.52B(-1.1%) |
Dec 2011 | $2.55B | $970.00M(+78.6%) | $2.55B(-11.7%) |
Sep 2011 | - | $543.00M(+6.3%) | $2.89B(-2.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2011 | - | $511.00M(-2.9%) | $2.95B(+2.8%) |
Mar 2011 | - | $526.00M(-59.8%) | $2.87B(+4.6%) |
Dec 2010 | $2.74B(+31.3%) | $1.31B(+117.1%) | $2.74B(+24.1%) |
Sep 2010 | - | $602.00M(+39.7%) | $2.21B(+6.7%) |
Jun 2010 | - | $431.00M(+7.5%) | $2.07B(-1.6%) |
Mar 2010 | - | $401.00M(-48.3%) | $2.10B(+0.8%) |
Dec 2009 | $2.09B(-20.3%) | $775.00M(+67.4%) | $2.09B(-6.8%) |
Sep 2009 | - | $463.00M(-0.2%) | $2.24B(-2.9%) |
Jun 2009 | - | $464.00M(+20.5%) | $2.31B(+0.1%) |
Mar 2009 | - | $385.00M(-58.5%) | $2.30B(-12.1%) |
Dec 2008 | $2.62B(+41.2%) | $927.00M(+74.9%) | $2.62B(+16.7%) |
Sep 2008 | - | $530.00M(+15.0%) | $2.25B(-1.5%) |
Jun 2008 | - | $461.00M(-34.3%) | $2.28B(+4.2%) |
Mar 2008 | - | $702.00M(+27.2%) | $2.19B(+17.9%) |
Dec 2007 | $1.86B(+38.0%) | $552.00M(-2.3%) | $1.86B(+7.2%) |
Sep 2007 | - | $565.00M(+53.1%) | $1.73B(+15.8%) |
Jun 2007 | - | $369.00M(-0.3%) | $1.50B(+4.4%) |
Mar 2007 | - | $370.00M(-13.6%) | $1.43B(+6.5%) |
Dec 2006 | $1.34B(+1.4%) | $428.00M(+30.1%) | $1.34B(+2.6%) |
Sep 2006 | - | $329.00M(+7.5%) | $1.31B(+2.0%) |
Jun 2006 | - | $306.00M(+8.5%) | $1.28B(-1.2%) |
Mar 2006 | - | $282.00M(-28.4%) | $1.30B(-2.0%) |
Dec 2005 | $1.33B(+4.7%) | $394.00M(+30.0%) | $1.33B(+1.7%) |
Sep 2005 | - | $303.00M(-5.6%) | $1.30B(+0.9%) |
Jun 2005 | - | $321.00M(+3.9%) | $1.29B(+1.4%) |
Mar 2005 | - | $309.00M(-16.9%) | $1.27B(+0.6%) |
Dec 2004 | $1.27B(-1.9%) | $372.00M(+27.8%) | $1.27B(-1.6%) |
Sep 2004 | - | $291.00M(-4.0%) | $1.29B(-12.9%) |
Jun 2004 | - | $303.00M(+0.3%) | $1.48B(+11.9%) |
Mar 2004 | - | $302.00M(-23.2%) | $1.32B(+2.3%) |
Dec 2003 | $1.29B(+34.7%) | $393.00M(-18.4%) | $1.29B(+11.3%) |
Sep 2003 | - | $481.84M(+230.7%) | $1.16B(+26.4%) |
Jun 2003 | - | $145.71M(-46.5%) | $919.16M(-8.6%) |
Mar 2003 | - | $272.45M(+4.2%) | $1.01B(+4.7%) |
Dec 2002 | $960.00M(+11.6%) | $261.54M(+9.2%) | $960.00M(+3.7%) |
Sep 2002 | - | $239.46M(+3.2%) | $925.46M(+3.4%) |
Jun 2002 | - | $232.00M(+2.2%) | $895.00M(+2.2%) |
Mar 2002 | - | $227.00M(0.0%) | $875.69M(+1.8%) |
Dec 2001 | $860.00M(-7.4%) | $227.00M(+8.6%) | $860.00M(+8.8%) |
Sep 2001 | - | $209.00M(-1.7%) | $790.44M(-5.9%) |
Jun 2001 | - | $212.69M(+0.7%) | $839.96M(-4.5%) |
Mar 2001 | - | $211.31M(+34.2%) | $879.67M(-5.3%) |
Dec 2000 | $929.02M(-13.1%) | $157.44M(-39.1%) | $929.02M(+20.4%) |
Sep 2000 | - | $258.52M(+2.4%) | $771.59M(+50.4%) |
Jun 2000 | - | $252.40M(-3.2%) | $513.07M(+96.8%) |
Mar 2000 | - | $260.66M | $260.66M |
Dec 1999 | $1.07B(+30.2%) | - | - |
Dec 1998 | $821.00M(+129.9%) | - | - |
Dec 1997 | $357.07M(-3.9%) | - | - |
Dec 1996 | $371.61M(+24.0%) | - | - |
Dec 1995 | $299.77M(+8.3%) | - | - |
Dec 1994 | $276.72M(+8.8%) | - | - |
Dec 1993 | $254.42M(+4.8%) | - | - |
Dec 1992 | $242.67M(-16.9%) | - | - |
Dec 1991 | $291.91M(-3.0%) | - | - |
Dec 1990 | $300.91M | - | - |
FAQ
- What is AstraZeneca annual depreciation & amortization?
- What is the all time high annual D&A for AstraZeneca?
- What is AstraZeneca annual D&A year-on-year change?
- What is AstraZeneca quarterly depreciation & amortization?
- What is the all time high quarterly D&A for AstraZeneca?
- What is AstraZeneca quarterly D&A year-on-year change?
- What is AstraZeneca TTM depreciation & amortization?
- What is the all time high TTM D&A for AstraZeneca?
- What is AstraZeneca TTM D&A year-on-year change?
What is AstraZeneca annual depreciation & amortization?
The current annual D&A of AZN is $6.69B
What is the all time high annual D&A for AstraZeneca?
AstraZeneca all-time high annual depreciation & amortization is $6.69B
What is AstraZeneca annual D&A year-on-year change?
Over the past year, AZN annual depreciation & amortization has changed by +$1.75B (+35.55%)
What is AstraZeneca quarterly depreciation & amortization?
The current quarterly D&A of AZN is $1.28B
What is the all time high quarterly D&A for AstraZeneca?
AstraZeneca all-time high quarterly depreciation & amortization is $2.79B
What is AstraZeneca quarterly D&A year-on-year change?
Over the past year, AZN quarterly depreciation & amortization has changed by +$29.00M (+2.31%)
What is AstraZeneca TTM depreciation & amortization?
The current TTM D&A of AZN is $5.09B
What is the all time high TTM D&A for AstraZeneca?
AstraZeneca all-time high TTM depreciation & amortization is $5.45B
What is AstraZeneca TTM D&A year-on-year change?
Over the past year, AZN TTM depreciation & amortization has changed by +$407.00M (+8.68%)